Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EPOPROSTENOL Cause Application site irritation? 48 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Application site irritation have been filed in association with EPOPROSTENOL (EPOPROSTENOL). This represents 0.4% of all adverse event reports for EPOPROSTENOL.

48
Reports of Application site irritation with EPOPROSTENOL
0.4%
of all EPOPROSTENOL reports
7
Deaths
40
Hospitalizations

How Dangerous Is Application site irritation From EPOPROSTENOL?

Of the 48 reports, 7 (14.6%) resulted in death, 40 (83.3%) required hospitalization.

Is Application site irritation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EPOPROSTENOL. However, 48 reports have been filed with the FAERS database.

What Other Side Effects Does EPOPROSTENOL Cause?

Dyspnoea (2,744) Headache (2,425) Diarrhoea (2,310) Nausea (2,016) Pain in jaw (1,928) Death (1,362) Flushing (1,256) Fatigue (1,133) Hospitalisation (1,078) Vomiting (1,068)

What Other Drugs Cause Application site irritation?

MINOXIDIL (1,826) BUPRENORPHINE (921) ESTRADIOL (624) NICOTINE (539) SUMATRIPTAN (392) TESTOSTERONE (390) ESTRADIOL\NORETHINDRONE (341) FENTANYL (271) METHYLPHENIDATE (235) ETHINYL ESTRADIOL\NORELGESTROMIN (139)

Which EPOPROSTENOL Alternatives Have Lower Application site irritation Risk?

EPOPROSTENOL vs EPTIFIBATIDE EPOPROSTENOL vs EPTINEZUMAB-JJMR EPOPROSTENOL vs EPTINEZUMAB\EPTINEZUMAB-JJMR EPOPROSTENOL vs EQUINE BOTULINUM NEUROTOXIN A/B/C/D/E/F/G IMMUNE FAB2 EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN

Related Pages

EPOPROSTENOL Full Profile All Application site irritation Reports All Drugs Causing Application site irritation EPOPROSTENOL Demographics